keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Lorpucitinib (JNJ-64251330) is an orally available, selective and potent JAK kinase inhibitor for the study of inflammatory and gastrointestinal disorders associated with Janus kinase (JAK) signaling.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 52,500 |
5 mg | 在庫あり | ¥ 131,500 |
10 mg | 在庫あり | ¥ 209,500 |
25 mg | 在庫あり | ¥ 397,000 |
50 mg | 在庫あり | ¥ 640,500 |
100 mg | 在庫あり | ¥ 865,500 |
説明 | Lorpucitinib (JNJ-64251330) is an orally available, selective and potent JAK kinase inhibitor for the study of inflammatory and gastrointestinal disorders associated with Janus kinase (JAK) signaling. |
別名 | JNJ-64251330 |
分子量 | 408.5 |
分子式 | C22H28N6O2 |
CAS No. | 2230282-02-5 |
keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL(244.80 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Lorpucitinib 2230282-02-5 Angiogenesis Chromatin/Epigenetic JAK/STAT signaling Stem Cells JAK JNJ-64251330 Inhibitor inhibitor inhibit